{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:32:26Z","timestamp":1786361546092,"version":"build-2736575974"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neural stem cell (NSC) therapeutics have emerged as a promising approach for addressing neurological disorders due to their inherent ability to self-renew, differentiate into neural lineages, and secrete neurotrophic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This narrative review explores the evolving clinical landscape of NSC applications, highlighting their therapeutic potential in neurodegenerative diseases, ischemic stroke, and spinal cord injuries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>Recent clinical advancements demonstrate the safety and preliminary efficacy of NSC-based therapies in conditions like Parkinson\u2019s disease and amyotrophic lateral sclerosis. NSCs\u2019 capacity to promote neuroplasticity and tissue restoration underscores their potential in reversing synaptic and neuronal damage. Despite these advancements, significant challenges remain. Ethical considerations, particularly concerning cell sourcing and patient consent, must be carefully navigated. Technical barriers, including cell delivery, survival, and long-term integration, require innovative solutions. Furthermore, safety concerns such as tumor formation and immune rejection necessitate rigorous preclinical and clinical assessments. Regulatory challenges, including the standardization of manufacturing processes and international harmonization, are essential for widespread adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Looking ahead, the integration of precision medicine, advanced biomaterials, and patient-specific-induced pluripotent stem cells offers promising approaches to enhance NSC therapeutics. Collaborative efforts between researchers, clinicians, and regulatory agencies are crucial for overcoming existing barriers and translating NSC research into clinical practice, offering new hope for patients with complex neurological conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004904","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:00:09Z","timestamp":1778079609000},"page":"3284-3295","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Translating potential into practice: the evolving landscape of neural stem cell therapeutics in clinical applications"],"prefix":"10.1097","volume":"88","author":[{"given":"Shreya Singh","family":"Beniwal","sequence":"first","affiliation":[{"name":"Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Rawat","sequence":"additional","affiliation":[{"name":"Himalayan Institute of Medical Sciences, Swami Ram Himalayan University, Dehradun, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurology, All India Institute of Medical Sciences (AIIMS), Bilaspur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Castro","family":"Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimuka","family":"Mwaanga","sequence":"additional","affiliation":[{"name":"University Lecturer in Medical Biochemistry, Texila American University Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0956-3252","authenticated-orcid":false,"given":"Valentina Ardila","family":"Mora","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, DC, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulkit","family":"Saini","sequence":"additional","affiliation":[{"name":"Sri Devaraj Urs Medical College, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Everton Assun\u00e7\u00e3o Ribeiro","family":"da Costa","sequence":"additional","affiliation":[{"name":"State University of Campinas, Cidade Universit\u00e1ria \u201cZeferino Vaz,\u201d Bar\u00e3o Geraldo, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-9803","authenticated-orcid":false,"given":"Anam Sayed","family":"Mushir Ali","sequence":"additional","affiliation":[{"name":"\u2060Indian Institute of Medical Science and Research, Jalna, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of General Medicine, NSMCH, Bihta, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1955-9116","authenticated-orcid":false,"given":"Ayush","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"Danylo Halytsky Lviv National Medical University, Lviv oblast, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubh Prashant","family":"Mehta","sequence":"additional","affiliation":[{"name":"B.J. Medical College, New Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv Rakeshkumar","family":"Patel","sequence":"additional","affiliation":[{"name":"B.J. Medical College, New Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranathi","family":"Danda","sequence":"additional","affiliation":[{"name":"Mediciti Institute of Medical Sciences, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"R1-20260810","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R2-20260810","doi-asserted-by":"crossref","first-page":"687\u2013700","DOI":"10.4252\/wjsc.v15.i7.687","article-title":"Neural stem cells for Parkinson\u2019s disease management: challenges, nanobased support, and prospects","volume":"15","author":"Oz","year":"2023","journal-title":"World J Stem Cells"},{"key":"R3-20260810","doi-asserted-by":"crossref","first-page":"502\u201311","DOI":"10.4252\/wjsc.v7.i2.502","article-title":"Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases","volume":"7","author":"Suksuphew","year":"2015","journal-title":"World J Stem Cells"},{"key":"R4-20260810","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fneur.2020.00148","article-title":"Therapeutic plasticity of neural stem cells","volume":"11","author":"Ottoboni","year":"2020","journal-title":"Front Neurol"},{"key":"R5-20260810","doi-asserted-by":"crossref","first-page":"1908\u201316","DOI":"10.4103\/1673-5374.367836","article-title":"New insights into the biological roles of immune cells in neural stem cells in post-traumatic injury of the central nervous system","volume":"18","author":"He","year":"2023","journal-title":"Neural Regen Res"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"126\u201336","DOI":"10.4252\/wjsc.v7.i1.126","article-title":"Adult human neural stem cell therapeutics: current developmental status and prospect","volume":"7","author":"Nam","year":"2015","journal-title":"World J Stem Cells"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"9978837","DOI":"10.1155\/2021\/9978837","article-title":"Stem cells: a historical review about biological, religious, and ethical issues","volume":"2021","author":"Charitos","year":"2021","journal-title":"Stem Cells Int"},{"key":"R8-20260810","doi-asserted-by":"crossref","first-page":"hoy024","DOI":"10.1093\/hropen\/hoy024","article-title":"Two decades of embryonic stem cells: a historical overview","volume":"2019","author":"Eguizabal","year":"2019","journal-title":"Hum Reprod Open"},{"key":"R9-20260810","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"R10-20260810","doi-asserted-by":"crossref","first-page":"1398\u2013408","DOI":"10.1016\/j.stemcr.2021.05.012","article-title":"ISSCR guidelines for stem cell research and clinical translation: the 2021 update","volume":"16","author":"Lovell-Badge","year":"2021","journal-title":"Stem Cell Rep"},{"key":"R11-20260810","doi-asserted-by":"crossref","first-page":"503\u201305","DOI":"10.1038\/mt.2013.24","article-title":"Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis","volume":"21","author":"Ferraiuolo","year":"2013","journal-title":"Mol Ther"},{"key":"R12-20260810","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/scrt313","article-title":"Clinical translation of human neural stem cells","volume":"4","author":"Tsukamoto","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"R13-20260810","doi-asserted-by":"crossref","first-page":"547\u201353","DOI":"10.1002\/sctm.19-0377","article-title":"Regulated, reliable, and reputable: protect patients with uniform standards for stem cell treatments","volume":"9","author":"Lomax","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"R14-20260810","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/ijms23052850","article-title":"Stem cell therapy: from idea to clinical practice","volume":"23","author":"Mousaei Ghasroldasht","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R15-20260810","doi-asserted-by":"crossref","first-page":"100053","DOI":"10.1016\/j.bea.2022.100053","article-title":"Neural stem cell engineering for the treatment of multiple sclerosis","volume":"4","author":"Ahmed","year":"2022","journal-title":"Biomed Eng Adv"},{"key":"R16-20260810","doi-asserted-by":"crossref","first-page":"616\u201332","DOI":"10.1080\/01616412.2021.1893564","article-title":"Overview of stem cells therapy in amyotrophic lateral sclerosis","volume":"43","author":"Je","year":"2021","journal-title":"Neurol Res"},{"key":"R17-20260810","first-page":"7\u201316","article-title":"Neural stem cells: therapeutic potential for neurodegenerative diseases","volume":"104","author":"Gincberg","year":"2012","journal-title":"Biochem Mol Biol Educ"},{"key":"R18-20260810","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41420-023-01532-9","article-title":"Directional induction of neural stem cells: a new therapy for neurodegenerative diseases and ischemic stroke","volume":"9","author":"Nie","year":"2023","journal-title":"Cell Death Discov"},{"key":"R19-20260810","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/biomedicines11020505","article-title":"Stem cell therapies in movement disorders: lessons from clinical trials","volume":"11","author":"Marsili","year":"2023","journal-title":"Biomedicines"},{"key":"R20-20260810","doi-asserted-by":"crossref","first-page":"619\u201328","DOI":"10.4103\/1673-5374.380874","article-title":"Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Chang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R21-20260810","doi-asserted-by":"crossref","first-page":"2205804","DOI":"10.1002\/advs.202205804","article-title":"Transplanting human neural stem cells with \u224850% reduction of SOX9 gene dosage promotes tissue repair and functional recovery from severe spinal cord injury","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci"},{"key":"R22-20260810","doi-asserted-by":"crossref","first-page":"363\u201373","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann Neurol"},{"key":"R23-20260810","doi-asserted-by":"crossref","first-page":"1813\u201322","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh","year":"2022","journal-title":"Nat Med"},{"key":"R24-20260810","doi-asserted-by":"crossref","first-page":"75\u201385","DOI":"10.1038\/s41591-022-02097-3","article-title":"Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study","volume":"29","author":"Genchi","year":"2023","journal-title":"Nat Med"},{"key":"R25-20260810","first-page":"8:e928","article-title":"Mesenchymal stem cell-derived neural progenitors in progressive MS: two-year follow-up of a phase I study","author":"Harris","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R26-20260810","doi-asserted-by":"crossref","first-page":"1103\u201314","DOI":"10.1016\/S1470-2045(21)00245-X","article-title":"Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial","volume":"22","author":"Fares","year":"2021","journal-title":"Lancet Oncol"},{"key":"R27-20260810","doi-asserted-by":"crossref","first-page":"101841","DOI":"10.1016\/j.xcrm.2024.101841","article-title":"Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury","volume":"5","author":"Martin","year":"2024","journal-title":"Cell Rep Med"},{"key":"R28-20260810","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12887-017-0859-z","article-title":"Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open-label uncontrolled clinical trial","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Pediatr"},{"key":"R29-20260810","doi-asserted-by":"crossref","first-page":"643\u201352","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"R30-20260810","doi-asserted-by":"crossref","first-page":"5312426","DOI":"10.1155\/2018\/5312426","article-title":"Early changes in tumor perfusion from T1-weighted dynamic contrast-enhanced MRI following neural stem cell-mediated therapy of recurrent high-grade glioma correlate with overall survival","volume":"2018","author":"Sahoo","year":"2018","journal-title":"Stem Cells Int"},{"key":"R31-20260810","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-022-03234-y","article-title":"Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: a randomised phase 1\/2 controlled trial","volume":"14","author":"Lv","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"R32-20260810","doi-asserted-by":"crossref","first-page":"269\u201385","DOI":"10.1177\/0963689718820271","article-title":"Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients: a case series study, safety and efficacy four years after surgery","volume":"28","author":"Madrazo","year":"2019","journal-title":"Cell Transplant"},{"key":"R33-20260810","first-page":"37\u201349","article-title":"Administration of autologous bone marrow-derived stem cells for treatment of cerebral palsy patients: a proof of concept","volume":"11","author":"Bansal","year":"2016","journal-title":"J Stem Cells"},{"key":"R34-20260810","doi-asserted-by":"crossref","first-page":"787\u201396","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"R35-20260810","first-page":"181\u201387","article-title":"The crossroads of neural stem cell development and tumorigenesis","volume":"2","author":"Yabut","year":"2016","journal-title":"Opera Medica Et Physiologica"},{"key":"R36-20260810","first-page":"217\u201327","article-title":"Primary brain tumors, neural stem cells, and brain tumor cancer cells: where is the link?","volume":"2","author":"Gieryng","year":"2009","journal-title":"Cancer Microenviron"},{"key":"R37-20260810","first-page":"346\u201362","article-title":"Stem cell therapy in neurological disorders: promises and concerns","volume":"3","author":"Hachimi-Idrissi","year":"2023","journal-title":"Explor Neuroprot Ther"},{"key":"R38-20260810","doi-asserted-by":"crossref","first-page":"36\u201345","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem Cell-Based therapy","volume":"15","author":"Volarevi\u0107","year":"2018","journal-title":"Int J Med Sci"},{"key":"R40-20260810","first-page":"45\u201366","article-title":"Drosophila neural stem cells in brain development and tumor formation","volume":"197","author":"Homem","year":"2014","journal-title":"Genetics"},{"key":"R41-20260810","doi-asserted-by":"crossref","first-page":"702951","DOI":"10.3389\/fimmu.2021.697203","article-title":"Immunological responses to Transgene-Modified neural stem cells after transplantation","volume":"12","author":"Wei","year":"2021","journal-title":"Front Immunol"},{"key":"R42-20260810","doi-asserted-by":"crossref","first-page":"284\u201388","DOI":"10.2174\/1874467208666150928153511","article-title":"Stem cell therapy and immunological rejection in animal models","volume":"9","author":"Jin","year":"2016","journal-title":"Curr Mol Pharmacol"},{"key":"R43-20260810","doi-asserted-by":"crossref","first-page":"262\u201378","DOI":"10.1007\/s12015-011-9266-2","article-title":"Current challenges for the advancement of neural stem cell biology and transplantation research","volume":"8","author":"Reekmans","year":"2012","journal-title":"Stem Cell Rev Rep"},{"key":"R44-20260810","doi-asserted-by":"crossref","first-page":"204\u201313","DOI":"10.1210\/er.2008-0031","article-title":"Ethical issues in stem cell research","volume":"30","author":"Lo","year":"2009","journal-title":"Endocr Rev"},{"key":"R45-20260810","doi-asserted-by":"crossref","first-page":"83\u201388","DOI":"10.1016\/j.gde.2014.09.007","article-title":"In vivo imaging of transplanted stem cells in the central nervous system","volume":"28","author":"Duffy","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"R47-20260810","doi-asserted-by":"crossref","first-page":"5549381","DOI":"10.1155\/2021\/5549381","article-title":"Intranasally administered L-Myc-immortalized human neural stem cells migrate to primary and distal sites of damage after cortical impact and enhance spatial learning","volume":"2021","author":"Gutova","year":"2021","journal-title":"Stem Cells Int"},{"key":"R49-20260810","doi-asserted-by":"crossref","first-page":"648472","DOI":"10.3389\/fcell.2021.648472","article-title":"Acceleration of translational mesenchymal stromal cell therapy through consistent quality GMP manufacturing","volume":"9","author":"Jayaraman","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R50-20260810","first-page":"1574\u201385","article-title":"Monitoring maturation of neural stem cell grafts within a host microenvironment","volume":"28","author":"Kopach","year":"2019","journal-title":"Cell Transplant"},{"key":"R51-20260810","first-page":"568\u201388","article-title":"Current state of stem cell based therapies: an overview","volume":"16","author":"Aly","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R52-20260810","doi-asserted-by":"crossref","first-page":"396\u2013401","DOI":"10.1136\/jnnp-2019-322515","article-title":"Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)","volume":"91","author":"Muir","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R53-20260810","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/scrt129","article-title":"US Food and Drug Administration international collaborations for cellular therapy product regulation","volume":"3","author":"Arcidiacono","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"R54-20260810","first-page":"846\u201357","article-title":"Stem cell therapy: a look at current research, regulations, and remaining hurdles","volume":"39","author":"Reisman","year":"2014","journal-title":"P T"},{"key":"R55-20260810","doi-asserted-by":"crossref","first-page":"106565","DOI":"10.1016\/j.clineuro.2021.106565","article-title":"Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series","volume":"203","author":"Honmou","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"R56-20260810","first-page":"80\u201388","article-title":"Safety and effectiveness of plerixafor for peripheral blood stem cell mobilization in autologous transplantation: post-marketing surveillance study","volume":"56","author":"Tsukada","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"R57-20260810","doi-asserted-by":"crossref","first-page":"1102\u201311","DOI":"10.1136\/jnnp-2023-332921","article-title":"Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson\u2019s disease","volume":"95","author":"Jiang","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R58-20260810","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","article-title":"Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis","volume":"30","author":"Leone","year":"2023","journal-title":"Cell Stem Cell"},{"key":"R59-20260810","doi-asserted-by":"crossref","first-page":"1383\u201399","DOI":"10.1093\/brain\/awaa080","article-title":"Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease","volume":"143","author":"Gruenenfelder","year":"2020","journal-title":"Brain"},{"key":"R60-20260810","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-023-01870-3","article-title":"Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"R61-20260810","doi-asserted-by":"crossref","first-page":"191\u2013202","DOI":"10.3109\/03009734.2012.665096","article-title":"Neural stem cells: brain building blocks and beyond","volume":"117","author":"Bergstr\u00f6m","year":"2012","journal-title":"Ups J Med Sci"},{"key":"R62-20260810","first-page":"1\u20139","article-title":"Biology and clinical application of neural stem cells","volume":"60Suppl 3","author":"Shimazaki","year":"2003","journal-title":"Horm Res"},{"key":"R63-20260810","first-page":"85\u201393","article-title":"Stem cell implants: emerging innovation for stroke recovery","volume":"5","author":"Colliander","year":"2023","journal-title":"J Neurooncol Res"},{"key":"R64-20260810","first-page":"1180\u201388","article-title":"Neural stem cells \u2013 trends and advances","volume":"114","author":"Ednk","year":"2013","journal-title":"J Cell Biochem"},{"key":"R65-20260810","doi-asserted-by":"crossref","first-page":"1\u201315","DOI":"10.1007\/s00441-017-2738-1","article-title":"Neural stem cells: developmental mechanisms and disease modeling","volume":"371","author":"Zhao","year":"2018","journal-title":"Cell Tissue Res"},{"key":"R66-20260810","doi-asserted-by":"crossref","first-page":"104162","DOI":"10.3389\/fnhum.2023.1197459","article-title":"The cerebellum and cognitive neural networks","volume":"17","author":"Zhang","year":"2023","journal-title":"Front Hum Neurosci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:01:00Z","timestamp":1786359660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004904","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"2025-03-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}